Figure 1 | Scientific Reports

Figure 1

From: Nemonoxacin achieved a better symptomatic improvement and a prolonged interval to next exacerbation than moxifloxacin for outpatients with acute exacerbations of chronic obstructive pulmonary disease

Figure 1

Comparison of the MCID response rate in CAT scores and TDI scores between the moxifloxacin group and the nemonoxacin group. (A) MCID response rate in CAT scores after 4 weeks; (B) MCID response rate in TDI scores after 4 weeks; (C) MCID response rate in CAT scores after 24 weeks; (D) MCID response rate in TDI scores after 24 weeks. CAT COPD assessment test, TDI transition dyspnea indices, MCID minimal clinically important differences, RR risk ratio.

Back to article page